Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Marseille
Clinical trial register · France

Clinical Trials in Marseille, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 35 Nice 32 Marseille 28 Toulouse 26 Montpellier 23
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Assistance Publique Hopitaux De Marseille91 AstraZeneca58 Institut Paoli-Calmettes40 Merck Sharp & Dohme LLC37 Novartis Pharmaceuticals36 Clear sponsor filter
Site location
Paris35 Nice32 Marseille28 Toulouse26 Montpellier23
All 72 locations
Target enrolment
to

Trials with a site in Marseille

28 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
AbbVie
Phase 3
531
Marseille
2026-07-02
Recruiting
AbbVie
Phase 2/3
660
Nice, Marseille, Pessac, Angers, Amiens, Paris
2026-06-30
Recruiting
AbbVie
Phase 2/3
490
Marseille, Brest, Lille, Montpellier, Paris
2025-12-10
Recruiting
AbbVie
Phase 3
561
Nice, Lyon, Bordeaux, Nantes, Écully, Créteil, Marseille, Paris
2025-11-05
Recruiting
AbbVie
Phase 1
135
Nice, Marseille, Lille, Tours, Toulouse
2025-08-07
Active, closed
AbbVie
Phase 2
150
Marseille, Suresnes, Villejuif
2025-01-20
Active, closed
AbbVie
Observational
250
Strasbourg, Clermont-Ferrand, Lyon, Marseille, Saint-Brieuc, Besançon, Brest, Limoges
2024-11-12
Active, closed
AbbVie
Phase 2
108
Marseille, Tours, Paris, Pierre-Bénite, Le Mans
2024-07-29
Active, closed
AbbVie
Phase 2/3
167
Marseille, La Tronche, Paris, Bron, Créteil
2024-04-10
Active, closed
AbbVie
Observational
1,200
Nice, Clermont, Lyon, Marseille, Dijon, Pessac, Toulouse, Montpellier
2024-02-19
Active, closed
AbbVie
Observational
1,019
Nice, Marseille, Besançon, Brest, Quimper, Nîmes, Pessac, Colmar
2023-06-09
Recruiting
AbbVie
Phase 1
210
Marseille, Créteil, Nantes, Pierre-Bénite, Poitiers, Paris
2023-03-21
Active, closed
AbbVie
Phase 3
520
Strasbourg, Marseille, Dijon, Brest, Lyon, Paris
2023-03-15
Active, closed
AbbVie
Observational
300
Saint-Quentin, Clermont, Marseille, Rennes, Dijon, Niort, Besançon, Romans-sur-Isère
2023-02-21
Active, closed
AbbVie
Observational
785
Nice, Marseille, Besançon, Nîmes, Colmar, Toulouse, Montpellier, La Tronche
2022-08-15
Recruiting
AbbVie
Phase 3
768
Marseille, Lille, Montpellier, Pessac, Paris, Avignon, Bron, Lyon
2022-03-25
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
DrugsEylea·Aflibercept
AbbVie
Phase 3
735
Nice, Lyon, Dijon, Toulouse, Paris, Nantes, Marseille, Créteil
2022-01-13
Active, closed
AbbVie
Phase 1
81
Marseille, Bordeaux, Paris, Dijon, Toulouse
2021-02-23
Active, closed
AbbVie
Phase 3
527
Nice, Clermont, Marseille, Pessac, Montpellier, La Tronche, Reims, Vandœuvre-lès-Nancy
2020-09-30
Active, closed
AbbVie
Phase 3
531
Nice, Pessac, La Tronche, Lille, Nantes, Marseille, Rouen, Avignon
2020-09-10
Active, closed
AbbVie
Phase 1/2
218
Marseille, Toulouse, Paris, Nice, Pierre-Bénite, Le Chesnay
2019-11-06
Active, closed
AbbVie
Phase 2
270
Marseille, Bordeaux, Lille, Paris, Bron, Lyon, Créteil, Villejuif
2018-10-10
Active, closed
AbbVie
Phase 3
1,242
Nice, Marseille, Montpellier, Vandœuvre-lès-Nancy, Pessac, Saint Priest EN Jarez, Amiens, Nantes
2018-08-28
Active, closed
AbbVie
Phase 3
1,533
Nice, Marseille, Tours, Bordeaux, Reims
2018-08-09
Active, closed
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
NCT03386513Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm
DrugIMGN632
AbbVie
Phase 1/2
179
Amiens, Besançon, Marseille, Paris, Pessac
2018-01-02
Active, closed
AbbVie
Phase 3
1,629
Toulouse, Lille, Montpellier, Bordeaux, Caen, Clermont-Ferrand, Marseille, Paris
2015-12-01
Active, closed
AbbVie
Phase 1
237
Marseille, Villejuif
2014-01-15
Active, closed
AbbVie
Observational
8,250
Nice, Clermont, Marseille, Toulouse, Montpellier, La Tronche, Reims, Vandœuvre-lès-Nancy
2013-04-29
Rows per page Showing 1–28 of 28
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/marseille

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 28 of those studies with a site in Marseille that also match the filters currently applied.

How many clinical trials are recruiting in Marseille?

7 of the 28 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 21 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Marseille), 28 studies
PhaseStudiesRecruitingShare
Phase 310335.7%
Observational6021.4%
Phase 14214.3%
Phase 23010.7%
Phase 2/33210.7%
Phase 1/2207.1%

Most active sponsors

Lead sponsors with the most studies (Marseille)
Lead sponsorStudiesRecruiting
AbbVie287
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.